ketamine has been researched along with Aura in 50 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We gained insights into NfL levels during the various phases of the intrahippocampal kainic acid mouse model of temporal lobe epilepsy-namely, the status epilepticus (SE) and the chronic phase with spontaneous seizures." | 8.31 | Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy? ( Barbé, K; Bjerke, M; Custers, ML; Kaltenböck, L; Smolders, I; Van Eeckhaut, A; Vande Vyver, M, 2023) |
| "This case series highlights the potential benefits of a ketamine-dexmedetomidine infusion combined with mild hypothermia for the treatment of status epilepticus refractory to GABAergic therapy in dogs suffering from idiopathic epilepsy." | 7.96 | Ketamine-dexmedetomidine combination and controlled mild hypothermia for the treatment of long-lasting and super-refractory status epilepticus in 3 dogs suffering from idiopathic epilepsy. ( D'Urso, ES; Di Cesare, F; Gioeni, D; Rabbogliatti, V; Ravasio, G, 2020) |
| " Here, we examine two neuroprotective agents, the noncompetitive NMDA antagonist ketamine and the dopaminergic antagonist acepromazine, for their efficacy in attenuating cognitive impairments in the lithium-pilocarpine (LI-PILO) model of rat limbic epilepsy." | 7.72 | Normal spatial and contextual learning for ketamine-treated rats in the pilocarpine epilepsy model. ( McKay, BE; Persinger, MA, 2004) |
| "A 6-year-old girl with severe epilepsy received an orthopedic surgery of the right hand under new total intravenous anesthesia with droperidol, fentanyl and ketamine." | 7.68 | [Clinical study on total intravenous anesthesia with droperidol, fentanyl and ketamine--5. An anesthetic experience of a pediatric patient with severe epilepsy]. ( Araki, I; Ishihara, H; Koh, H; Matsuki, A; Shirasaki, S; Takagi, H, 1991) |
| "Secondary outcome measures are postoperative pain intensity scores, psychological parameters, length of hospital stay and adverse events and will be reassessed at 3 and 6 months after surgery, with a baseline measurement preoperatively." | 6.90 | Assessing the effectiveness of perioperative s-ketamine on new-onset headache after resective epilepsy surgery (ESPAIN-trial): protocol for a randomised, double-blind, placebo-controlled trial. ( Bastiaenen, C; Bos, M; Colon, A; Dings, J; Hoogland, G; Rijkers, K; Rouhl, RPW; Schijns, OEMG; Sloekers, JCT; Theunissen, M; van Kuijk, S, 2019) |
| "Migraine aura is probably caused by cortical-spreading depression." | 5.31 | Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. ( Dichgans, M; Diener, HC; Herzog, J; Kaube, H; Käufer, T, 2000) |
| "This article will review the different therapeutic options for status, from early treatment at home to the different first-line (benzodiazepines), second-line (phenobarbital, valproic acid, phenytoin, levetiracetam and lacosamide) or third-line treatments, which include both pharmacological (anaesthetics, propofol, ketamine, lidocaine, topiramate, brivaracetam or perampanel) and non-pharmacological (ketogenic diet, immunomodulatory treatments or epilepsy surgery) therapies." | 5.22 | [Paediatric status epilepticus]. ( García-Peñas, JJ; González-Alguacil, E; Soto-Insuga, V, 2022) |
| "We gained insights into NfL levels during the various phases of the intrahippocampal kainic acid mouse model of temporal lobe epilepsy-namely, the status epilepticus (SE) and the chronic phase with spontaneous seizures." | 4.31 | Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy? ( Barbé, K; Bjerke, M; Custers, ML; Kaltenböck, L; Smolders, I; Van Eeckhaut, A; Vande Vyver, M, 2023) |
| "Pregabalin (PGB) is used in drug-resistant epilepsy." | 4.31 | The investigation of antidepressant and anxiolytic effects of pregabalin and its mechanisms of action in rats. ( Aydın, Ş; Çivgin, ME; Dinçer Öner, S; Kılıç Tatlıcı, C; Kılıç, FS; Yazıcı, ZG; Yıldırım, C, 2023) |
| "This case series highlights the potential benefits of a ketamine-dexmedetomidine infusion combined with mild hypothermia for the treatment of status epilepticus refractory to GABAergic therapy in dogs suffering from idiopathic epilepsy." | 3.96 | Ketamine-dexmedetomidine combination and controlled mild hypothermia for the treatment of long-lasting and super-refractory status epilepticus in 3 dogs suffering from idiopathic epilepsy. ( D'Urso, ES; Di Cesare, F; Gioeni, D; Rabbogliatti, V; Ravasio, G, 2020) |
| " We examined the behavior of rats treated with one of two potentially neuroprotective agents, the N-methyl-D-aspartate antagonist ketamine and the atypical neuroleptic acepromazine, on seizures induced by lithium-pilocarpine." | 3.72 | The neuromatrix and the epileptic brain: behavioral and learning preservation in limbic epileptic rats treated with ketamine but not acepromazine. ( Fournier, NM; Persinger, MA, 2004) |
| " Here, we examine two neuroprotective agents, the noncompetitive NMDA antagonist ketamine and the dopaminergic antagonist acepromazine, for their efficacy in attenuating cognitive impairments in the lithium-pilocarpine (LI-PILO) model of rat limbic epilepsy." | 3.72 | Normal spatial and contextual learning for ketamine-treated rats in the pilocarpine epilepsy model. ( McKay, BE; Persinger, MA, 2004) |
| "The cobalt model of epilepsy, in combination with the C-14 2-deoxyglucose (2-DG) autoradiographic technique, was used to assess the effects of phenytoin (PHT) and ethosuximide (ESM), two antiepileptic drugs, and ketamine (KET), a drug with anticonvulsant properties, on brain activity." | 3.69 | A combined cobalt and C-14 2-deoxyglucose approach to antiepileptic drug assessment. ( Cooper, RM; Krenz, NR, 1996) |
| " In this present study we have investigated the effects of DMI and ketamine on both NMDA-induced and spontaneous depolarizing shifts in cortical wedges prepared from genetically epilepsy-prone mice (DBA/2)." | 3.68 | Desmethylimipramine potentiates NMDA responses in a mouse cortical slice preparation. ( Davies, JA; Lancaster, JM, 1991) |
| "A 6-year-old girl with severe epilepsy received an orthopedic surgery of the right hand under new total intravenous anesthesia with droperidol, fentanyl and ketamine." | 3.68 | [Clinical study on total intravenous anesthesia with droperidol, fentanyl and ketamine--5. An anesthetic experience of a pediatric patient with severe epilepsy]. ( Araki, I; Ishihara, H; Koh, H; Matsuki, A; Shirasaki, S; Takagi, H, 1991) |
| "The effects of ketamine and (+)cyclazocine on three in vitro models of epilepsy: the "Mg2+ free", the 4-aminopyridine (4-AP) and, for comparison, the penicillin model were studied." | 3.67 | Effects of ketamine and (+)cyclazocine on 4-aminopyridine and "magnesium free" epileptogenic activity in hippocampal slices of rats. ( de Carolis, AS; Frank, C; Sagratella, S, 1987) |
| "Secondary outcome measures are postoperative pain intensity scores, psychological parameters, length of hospital stay and adverse events and will be reassessed at 3 and 6 months after surgery, with a baseline measurement preoperatively." | 2.90 | Assessing the effectiveness of perioperative s-ketamine on new-onset headache after resective epilepsy surgery (ESPAIN-trial): protocol for a randomised, double-blind, placebo-controlled trial. ( Bastiaenen, C; Bos, M; Colon, A; Dings, J; Hoogland, G; Rijkers, K; Rouhl, RPW; Schijns, OEMG; Sloekers, JCT; Theunissen, M; van Kuijk, S, 2019) |
| "Ketamine augmentation was associated with higher rates of confusion/disorientation/prolonged delirium (OR = 6." | 2.52 | A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability. ( Berlim, MT; Bond, DJ; Chan, PY; Lam, RW; McGirr, A; Neufeld, NH; Yatham, LN, 2015) |
| "Problematic compounds may cause seizures either acutely or on withdrawal: Their use may reduce effectiveness of antiepileptic drugs, or may simply promote and enhance chaotic lifestyles." | 2.48 | Alcohol and drugs in epilepsy: pathophysiology, presentation, possibilities, and prevention. ( Borland, W; Leach, JP; Mohanraj, R, 2012) |
| "The true incidence of seizures caused by general anesthetic drugs is unknown." | 2.44 | The howling cortex: seizures and general anesthetic drugs. ( Barnard, JP; Kirsch, HE; Sleigh, JW; Voss, LJ, 2008) |
| "Spontaneous seizures have been observed in several baboon species housed at the Southwest National Primate Research Center (SNPRC), including Papio hamadryas anubis and cynocephalus/anubis, hamadryas/anubis, and papio/anubis hybrids." | 1.32 | Scalp EEG for the diagnosis of epilepsy and photosensitivity in the baboon. ( Haines, R; Leland, MM; Mahaney, MA; Restrepo, S; Szabó, CA; Sztonák, L; Williams, JT, 2004) |
| "Migraine aura is probably caused by cortical-spreading depression." | 1.31 | Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine. ( Dichgans, M; Diener, HC; Herzog, J; Kaube, H; Käufer, T, 2000) |
| "Ketamine was equipotent for both phenomena in 25-day-old rats and, in contrast, it decreased more AD duration than WDS number in 90-day-old rats." | 1.29 | Developmental changes of ketamine action against epileptic afterdischarges induced by hippocampal stimulation in rats. ( Mares, P; Mikolásová, R; Velísek, L; Vorlícek, J, 1994) |
| "Ketamine was administered IP 5 min after the first AD in doses of 5, 10, 20, or 40 mg/kg." | 1.29 | Suppression of cortical epileptic afterdischarges by ketamine is not stable during ontogenesis in rats. ( Kubová, H; Mares, P, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (24.00) | 18.7374 |
| 1990's | 15 (30.00) | 18.2507 |
| 2000's | 9 (18.00) | 29.6817 |
| 2010's | 8 (16.00) | 24.3611 |
| 2020's | 6 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soto-Insuga, V | 1 |
| González-Alguacil, E | 1 |
| García-Peñas, JJ | 1 |
| Custers, ML | 1 |
| Vande Vyver, M | 1 |
| Kaltenböck, L | 1 |
| Barbé, K | 1 |
| Bjerke, M | 1 |
| Van Eeckhaut, A | 1 |
| Smolders, I | 1 |
| Aydın, Ş | 1 |
| Kılıç Tatlıcı, C | 1 |
| Çivgin, ME | 1 |
| Yazıcı, ZG | 1 |
| Yıldırım, C | 1 |
| Dinçer Öner, S | 1 |
| Kılıç, FS | 1 |
| Sloekers, JCT | 1 |
| Bos, M | 1 |
| Hoogland, G | 1 |
| Bastiaenen, C | 1 |
| van Kuijk, S | 1 |
| Theunissen, M | 1 |
| Rijkers, K | 1 |
| Dings, J | 1 |
| Colon, A | 1 |
| Rouhl, RPW | 1 |
| Schijns, OEMG | 1 |
| Samanta, D | 1 |
| Huntsman, RJ | 1 |
| Gioeni, D | 1 |
| Di Cesare, F | 1 |
| D'Urso, ES | 1 |
| Rabbogliatti, V | 1 |
| Ravasio, G | 1 |
| McGirr, A | 2 |
| Berlim, MT | 1 |
| Bond, DJ | 1 |
| Neufeld, NH | 1 |
| Chan, PY | 1 |
| Yatham, LN | 1 |
| Lam, RW | 1 |
| Barbier, L | 1 |
| Canini, F | 1 |
| Giroud, C | 1 |
| Beaup, C | 1 |
| Foquin, A | 1 |
| Maury, R | 1 |
| Denis, J | 1 |
| Peinnequin, A | 1 |
| Dorandeu, F | 2 |
| Fond, G | 1 |
| Boyer, L | 1 |
| Akay, A | 1 |
| Rükşen, M | 1 |
| Çetin, HY | 1 |
| Seval, HÖ | 1 |
| İşlekel, S | 1 |
| Voss, LJ | 1 |
| Sleigh, JW | 1 |
| Barnard, JP | 1 |
| Kirsch, HE | 1 |
| Carpentier, P | 1 |
| Dhote, F | 1 |
| Mion, G | 1 |
| Baille, V | 1 |
| Testylier, G | 1 |
| Lallement, G | 1 |
| Eker, HE | 1 |
| Yalcin Cok, O | 1 |
| Aribogan, A | 1 |
| Arslan, G | 1 |
| Leach, JP | 1 |
| Mohanraj, R | 1 |
| Borland, W | 1 |
| Szakács, R | 1 |
| Weiczner, R | 1 |
| Mihály, A | 1 |
| Krisztin-Péva, B | 1 |
| Zádor, Z | 1 |
| Zádor, E | 1 |
| Fournier, NM | 1 |
| Persinger, MA | 2 |
| Szabó, CA | 1 |
| Leland, MM | 1 |
| Sztonák, L | 1 |
| Restrepo, S | 1 |
| Haines, R | 1 |
| Mahaney, MA | 1 |
| Williams, JT | 1 |
| McKay, BE | 1 |
| Sharp, FR | 1 |
| Hendren, RL | 1 |
| Bourn, WM | 1 |
| Yang, DJ | 1 |
| Davisson, JN | 1 |
| Koch, D | 1 |
| Opitz, A | 1 |
| Degen, R | 1 |
| Mikolásová, R | 1 |
| Velísek, L | 2 |
| Vorlícek, J | 1 |
| Mares, P | 3 |
| De Sarro, GB | 1 |
| De Sarro, A | 1 |
| Gean, PW | 1 |
| Chang, FC | 1 |
| Hung, CR | 1 |
| Kubová, H | 2 |
| Krenz, NR | 1 |
| Cooper, RM | 1 |
| Timofeev, I | 2 |
| Grenier, F | 2 |
| Steriade, M | 2 |
| Królicki, L | 1 |
| Bacia, T | 2 |
| Graban, W | 1 |
| Mikołajków, A | 1 |
| Trabka, W | 1 |
| Bendarzewska-Nawrocka, B | 1 |
| Rysz, A | 1 |
| Bachański, M | 1 |
| Bidziński, J | 1 |
| Ishihara, H | 2 |
| Khanna, N | 1 |
| Bhalla, S | 1 |
| Kaube, H | 1 |
| Herzog, J | 1 |
| Käufer, T | 1 |
| Dichgans, M | 1 |
| Diener, HC | 1 |
| Doenicke, A | 1 |
| Evans, DE | 1 |
| Celesia, GG | 1 |
| Chen, RC | 1 |
| Bamforth, BJ | 1 |
| Lanstiakova, M | 1 |
| Vankova, S | 1 |
| Daló, NL | 1 |
| Piña-Crespo, JC | 1 |
| Lancaster, JM | 1 |
| Davies, JA | 1 |
| Lee, WL | 1 |
| Hablitz, JJ | 1 |
| Koh, H | 1 |
| Takagi, H | 1 |
| Araki, I | 1 |
| Shirasaki, S | 1 |
| Matsuki, A | 1 |
| Schneiderman, JH | 1 |
| MacDonald, JF | 1 |
| Sagratella, S | 1 |
| Frank, C | 1 |
| de Carolis, AS | 1 |
| Aram, JA | 1 |
| Lodge, D | 1 |
| Rucci, FS | 1 |
| Caroli, G | 1 |
| Bennett, DR | 1 |
| Madsen, JA | 1 |
| Jordan, WS | 1 |
| Wiser, WC | 1 |
| Turitto, P | 1 |
| Fiume-Garelli, F | 1 |
| Pagnoni, B | 1 |
| Wyant, GM | 1 |
6 reviews available for ketamine and Aura
| Article | Year |
|---|---|
[Paediatric status epilepticus].
Topics: Adult; Anesthetics; Anticonvulsants; Benzodiazepines; Child; Epilepsy; Humans; Ketamine; Lacosamide; | 2022 |
A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability.
Topics: Animals; Anticonvulsants; Electroconvulsive Therapy; Epilepsy; Humans; Ketamine; Randomized Controll | 2015 |
The howling cortex: seizures and general anesthetic drugs.
Topics: Anesthesia; Anesthetics, General; Animals; Dystonia; Electroencephalography; Epilepsy; Humans; Ketam | 2008 |
Alcohol and drugs in epilepsy: pathophysiology, presentation, possibilities, and prevention.
Topics: Alcohol Drinking; Alcohol Withdrawal Seizures; Alcoholism; Amphetamine-Related Disorders; Benzodiaze | 2012 |
Psychosis: atypical limbic epilepsy versus limbic hyperexcitability with onset at puberty?
Topics: Adolescent; Animals; Antipsychotic Agents; Dizocilpine Maleate; Epilepsy; Excitatory Amino Acid Anta | 2007 |
[Applicability of intravenous anesthesia--special reference to propofol and ketamine].
Topics: Anesthesia, Intravenous; Anesthetics, Dissociative; Anesthetics, Inhalation; Anesthetics, Intravenou | 1999 |
2 trials available for ketamine and Aura
| Article | Year |
|---|---|
Assessing the effectiveness of perioperative s-ketamine on new-onset headache after resective epilepsy surgery (ESPAIN-trial): protocol for a randomised, double-blind, placebo-controlled trial.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Analgesics, Opioid; Double-Blind Method; Drug Combinations; | 2019 |
Children on phenobarbital monotherapy requires more sedatives during MRI.
Topics: Anesthetics, Dissociative; Anticonvulsants; Child; Child, Preschool; Conscious Sedation; Double-Blin | 2011 |
42 other studies available for ketamine and Aura
| Article | Year |
|---|---|
Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy?
Topics: Animals; Biomarkers; Diazepam; Epilepsy; Intermediate Filaments; Kainic Acid; Ketamine; Mice; Neurof | 2023 |
The investigation of antidepressant and anxiolytic effects of pregabalin and its mechanisms of action in rats.
Topics: Amitriptyline; Animals; Anti-Anxiety Agents; Antidepressive Agents; Epilepsy; Fluoxetine; Humans; Ke | 2023 |
Ketamine in Refractory Neonatal Seizures.
Topics: Epilepsy; Humans; Infant, Newborn; Infant, Newborn, Diseases; Ketamine; Seizures; Status Epilepticus | 2020 |
Response to Samanta "Are Ketamine Infusions a Viable Therapeutic Option for Refractory Neonatal Seizures?"
Topics: Analgesics; Epilepsy; Humans; Infant, Newborn; Ketamine; Seizures | 2020 |
Ketamine-dexmedetomidine combination and controlled mild hypothermia for the treatment of long-lasting and super-refractory status epilepticus in 3 dogs suffering from idiopathic epilepsy.
Topics: Analgesics; Anesthesia, General; Animals; Body Temperature; Dexmedetomidine; Dog Diseases; Dogs; Epi | 2020 |
The safety and efficacy of adjunctive ketamine in electroconvulsive therapy: Response to Drs. Fond and Boyer.
Topics: Animals; Anticonvulsants; Electroconvulsive Therapy; Epilepsy; Humans; Ketamine | 2015 |
Beneficial effects of a ketamine/atropine combination in soman-poisoned rats under a neutral thermal environment.
Topics: Animals; Anticonvulsants; Atropine; Body Temperature; Brain; Brain Injuries; Chemical Warfare Agents | 2015 |
Ketamine vs other anesthetic agents for electroconvulsive therapy (ECT) in major depression.
Topics: Animals; Anticonvulsants; Electroconvulsive Therapy; Epilepsy; Humans; Ketamine | 2015 |
Pediatric Awake Craniotomy for Brain Lesions.
Topics: Adolescent; Aphasia, Broca; Brain; Brain Neoplasms; Broca Area; Craniotomy; Epilepsy; Female; Glioma | 2016 |
Re: Therapy against organophosphate poisoning: the importance of anticholinergic drugs with antiglutamatergic properties (Toxicol. Appl. Pharmacol. 232, 351-358, 2008).
Topics: Animals; Atropine; Brain Damage, Chronic; Cholinergic Antagonists; Drug Combinations; Epilepsy; Exci | 2009 |
Non-competitive NMDA receptor antagonists moderate seizure-induced c-fos expression in the rat cerebral cortex.
Topics: 4-Aminopyridine; Amantadine; Animals; Behavior, Animal; Cerebral Cortex; Dizocilpine Maleate; Dopami | 2003 |
The neuromatrix and the epileptic brain: behavioral and learning preservation in limbic epileptic rats treated with ketamine but not acepromazine.
Topics: Acepromazine; Analysis of Variance; Animals; Antipsychotic Agents; Behavior, Animal; Brain; Chi-Squa | 2004 |
Scalp EEG for the diagnosis of epilepsy and photosensitivity in the baboon.
Topics: Animals; Electroencephalography; Epilepsy; Ketamine; Monkey Diseases; Papio; Photic Stimulation; Pho | 2004 |
Normal spatial and contextual learning for ketamine-treated rats in the pilocarpine epilepsy model.
Topics: Animals; Disease Models, Animal; Epilepsy; Ketamine; Male; Maze Learning; Pilocarpine; Rats; Rats, W | 2004 |
Effect of ketamine enantiomers on sound-induced convulsions in epilepsy prone rats.
Topics: Acoustic Stimulation; Animals; Epilepsy; Ketamine; Male; Rats; Seizures; Stereoisomerism | 1983 |
[Intravenous anesthesia in patients with cerebral spasms].
Topics: Anesthesia, Intravenous; Epilepsy; Etomidate; Ketamine; Methohexital; Thiopental | 1981 |
Developmental changes of ketamine action against epileptic afterdischarges induced by hippocampal stimulation in rats.
Topics: Age Factors; Animals; Anticonvulsants; Behavior, Animal; Disease Models, Animal; Dose-Response Relat | 1994 |
Anticonvulsant properties of non-competitive antagonists of the N-methyl-D-aspartate receptor in genetically epilepsy-prone rats: comparison with CPPene.
Topics: Acoustic Stimulation; Adrenergic alpha-Antagonists; Animals; Anticonvulsants; Dextromethorphan; Dizo | 1993 |
Use-dependent modification of a slow NMDA receptor-mediated synaptic potential in rat amygdalar slices.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Amygdala; Animals; Bicuculline; Electrophysiology; E | 1993 |
Suppression of cortical epileptic afterdischarges by ketamine is not stable during ontogenesis in rats.
Topics: Animals; Anticonvulsants; Cerebral Cortex; Dose-Response Relationship, Drug; Electric Stimulation; E | 1995 |
A combined cobalt and C-14 2-deoxyglucose approach to antiepileptic drug assessment.
Topics: Animals; Anticonvulsants; Antimetabolites; Autoradiography; Brain Chemistry; Cobalt; Deoxyglucose; D | 1996 |
Spike-wave complexes and fast components of cortically generated seizures. IV. Paroxysmal fast runs in cortical and thalamic neurons.
Topics: Adrenergic alpha-Agonists; Anesthetics, Dissociative; Animals; Barbiturates; Cats; Cerebral Cortex; | 1998 |
CBF evaluation before and after ketamine or brietal activation of the epileptic discharges.
Topics: Adolescent; Adult; Anesthetics, Intravenous; Brain; Epilepsy; Excitatory Amino Acid Antagonists; Fem | 1998 |
[The comparison of ketamine with methohexital and thiopental in the intraoperative EEG in drug-resistant epilepsy].
Topics: Adolescent; Adult; Anesthetics, Intravenous; Anticonvulsants; Child; Child, Preschool; Drug Resistan | 1998 |
Role of ketamine in convulsions.
Topics: Animals; Anticonvulsants; Diazepam; Dose-Response Relationship, Drug; Drug Interactions; Drug Therap | 1999 |
Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine.
Topics: Administration, Intranasal; Adult; Calcium Channels, P-Type; Calcium Channels, Q-Type; Epilepsy; Exc | 2000 |
Focal synchronization of ripples (80-200 Hz) in neocortex and their neuronal correlates.
Topics: Action Potentials; Adrenergic alpha-Agonists; Anesthetics, Dissociative; Anesthetics, Inhalation; An | 2001 |
[Pharmacodynamics of some hypno-analgetics].
Topics: Analgesics; Electroencephalography; Enflurane; Epilepsy; Humans; Ketamine | 1977 |
Anaesthesia and the epileptic pateint. A review.
Topics: Adult; Anesthesia, General; Anticonvulsants; Barbiturates; Central Nervous System; Child, Preschool; | 1975 |
Effects of ketamine in epilepsy.
Topics: Adolescent; Adult; Behavior; Brain; Electroencephalography; Epilepsy; Female; Humans; Injections, In | 1975 |
Ketamine blocks cortical epileptic afterdischarges but not paired-pulse and frequency potentiation.
Topics: Animals; Cerebral Cortex; Electric Stimulation; Electroencephalography; Epilepsy; Evoked Potentials; | 1992 |
Ketamine abolishes the tonic phase of the seizures evoked by sudden cooling of toad isolated spinal cords.
Topics: Animals; Bufo marinus; Cold Temperature; Epilepsy; In Vitro Techniques; Ketamine; Spinal Cord; Time | 1992 |
Desmethylimipramine potentiates NMDA responses in a mouse cortical slice preparation.
Topics: Action Potentials; Animals; Anticonvulsants; Cerebral Cortex; Convulsants; Corpus Callosum; Desipram | 1991 |
Effect of APV and ketamine on epileptiform activity in the CA1 and CA3 regions of the hippocampus.
Topics: 2-Amino-5-phosphonovalerate; Animals; Epilepsy; Hippocampus; Ketamine; Male; Neurons; Rats; Rats, In | 1990 |
[Clinical study on total intravenous anesthesia with droperidol, fentanyl and ketamine--5. An anesthetic experience of a pediatric patient with severe epilepsy].
Topics: Anesthesia, Intravenous; Child; Droperidol; Epilepsy; Female; Fentanyl; Humans; Ketamine; Orthopedic | 1991 |
Excitatory amino acid blockers differentially affect bursting of in vitro hippocampal neurons in two pharmacological models of epilepsy.
Topics: 2-Amino-5-phosphonovalerate; Action Potentials; Animals; Epilepsy; Guinea Pigs; Hippocampus; In Vitr | 1989 |
Effects of ketamine and (+)cyclazocine on 4-aminopyridine and "magnesium free" epileptogenic activity in hippocampal slices of rats.
Topics: 2-Amino-5-phosphonovalerate; 4-Aminopyridine; Aminopyridines; Animals; Aspartic Acid; Cyclazocine; E | 1987 |
Epileptiform activity induced by alkalosis in rat neocortical slices: block by antagonists of N-methyl-D-aspartate.
Topics: 2-Amino-5-phosphonovalerate; Alkalosis; Animals; Aspartic Acid; Cerebral Cortex; Epilepsy; In Vitro | 1987 |
Letter: Ketamine and eclampsia.
Topics: Adolescent; Adult; Blood Pressure; Eclampsia; Epilepsy; Female; Humans; Ketamine; Pregnancy | 1974 |
Ketamine anesthesia in brain-damaged epileptics. Electroencephalographic and clinical observations.
Topics: Adolescent; Adult; Anesthesia, Dental; Brain Damage, Chronic; Carbon Dioxide; Child; Child, Preschoo | 1973 |
[Ketamine and epilepsy. Case report].
Topics: Child; Epilepsy; Humans; Ketamine; Male; Myotonia; Seizures | 1974 |
Intramuscular ketalar (CI-581) in paediatric anaesthesia.
Topics: Age Factors; Analgesics; Anesthesia, General; Blood Pressure; Bone Neoplasms; Child; Child, Preschoo | 1971 |